CClinicalTrials.gg
CompletedNCT01111032Updated Oct 1, 2013

Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer

An observational study in Cancer, sponsored by Hamilton Health Sciences Corporation. Completed at 1 site in Canada. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2013-10-01.

Sponsored by Hamilton Health Sciences Corporation · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
12
Ages
16 Years and older
Sex
All
01

Study summary

During this study the investigators will compare the use of two treadmill tests in people diagnosed with cancer. The STEEP treadmill protocol is often used to evaluate the endurance of people diagnosed with cancer, however, since it is based on step increases in speed or ramp, it may not related to normal function. The new test, which is based on the body response to increased activity has not been used with people with cancer but may provide a better approximation of endurance demands during daily function. Our question is whether the new treadmill test can be used to evaluate aerobic function with people with cancer better than the STEEP treadmill test.

02

Conditions studied

  • Cancer

Keywords

  • Treadmill
  • Exercise
  • Cancer
  • Validity
  • Reliability
03

In context

Lead sponsor

Hamilton Health Sciences Corporation is the lead sponsor of 237 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult well cancer survivors

Inclusion criteria

  • Participants are required to be adults (age 16 or over),
  • Diagnosed with cancer, at any stage of treatment (during or after treatment),
  • Able to follow instructions in English, and provide informed consent.
  • Participants need to be considered "well" to participate. A "well participant" has been defined as a cancer survivor who is living at home, able to ambulate independently without a gait aid (single point cane is acceptable), has no acute medical conditions, and passes pre-exercise safety screening.

Exclusion criteria

Exclusion Criteria:

  • Cancer survivors with metastatic disease.
  • Cancer survivors who are defined as unwell.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
12 participants (actual)

Groups and cohorts

  • Treadmill test
06

What researchers measure

Primary outcomes

  1. STEEP treadmill test

    Treadmill test for endurance. Lasts approx 15 min with 45 min recovery

    Time frame: 1 hour

07

Study locations

1 site
  • Hamilton Health Sciences, Henderson Campus
    Hamilton, Ontario L8V 1C3, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01111032
Lead sponsor
Hamilton Health Sciences Corporation
Collaborators
McMaster University
Responsible party
Oren Cheifetz (Clinical Specialist - Physiotherapy, McMaster University) — Principal investigator
First posted
Apr 27, 2010
Start date
May 2011
Primary completion
Oct 2011
Completion
Dec 2011
Last update
Oct 1, 2013

Study contacts

Oren Cheifetz, M.Sc. PT
principal investigator · Hamilton Health Sciences Corporation

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion